SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about outcome of board meeting

21 Oct 2015 Evaluate

Sanofi India has informed that the Board of Directors of the Company at its meeting held October 20, 2015, re-appointed Dr. Shailesh Ayyangar as Managing Director of the Company for a further term of five years from October 25, 2015, subject to approval of the shareholders in General Meeting. Dr. Ayyangar had been designated Managing Director of the Company on October 25, 2005. He was subsequently re-appointed as Managing Director for a term of five years from October 25, 2010.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3559.80 -0.20 (-0.01%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×